Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,923,078
in 11 filings, $11.2M under 10b5-1 plans

Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MIGNONE ROBERTO −$14.4M Director sold 100% of stake
  2. Francis Richard D −$10.6M President and CEO sold 21% of stake
  3. Sabag Mark −$3.9M See "Remarks" sold 53% of stake
  4. Daniell Richard −$1.9M EVP, Europe Commercial sold 45% of stake
  5. Weiss Amir −$1.1M Chief Accounting Officer sold 88% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-04 Hughes Eric A See "Remarks" Sale 10b5-1 −11,277 $32.46 $366K 97,590
2026-03-04 Hughes Eric A See "Remarks" Option exercise · Restricted Share Units 10b5-1 −23,251 46,503
2026-03-04 Hughes Eric A See "Remarks" Grant or award · Restricted Share Units 10b5-1 +50,643 50,643
2026-03-04 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise +33,512 282,268
2026-03-04 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise +23,251 305,519
2026-03-04 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise · Restricted Share Units −33,512 0
2026-03-04 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise · Restricted Share Units −23,251 46,503
2026-03-04 Kalif Eliyahu Sharon EVP, Chief Financial Officer Grant or award · Restricted Share Units +53,175 53,175
2026-03-04 Fox Christine EVP, U.S. Commercial Option exercise 10b5-1 +20,461 84,108
2026-03-04 Fox Christine EVP, U.S. Commercial Sale 10b5-1 −9,098 $32.46 $295K 75,010
2026-03-04 Fox Christine EVP, U.S. Commercial Option exercise · Restricted Share Units 10b5-1 −20,461 40,923
2026-03-04 Fox Christine EVP, U.S. Commercial Grant or award · Restricted Share Units 10b5-1 +50,643 50,643
2026-03-04 Savage Brian Interim Chief Legal Officer Option exercise +4,744 7,670
2026-03-04 Savage Brian Interim Chief Legal Officer Sale −1,489 $32.46 $48K 6,181
2026-03-04 Savage Brian Interim Chief Legal Officer Option exercise +3,466 9,647
2026-03-04 Savage Brian Interim Chief Legal Officer Sale −1,186 $32.46 $39K 8,461
2026-03-04 Savage Brian Interim Chief Legal Officer Option exercise · Restricted Share Units −4,744 0
2026-03-04 Savage Brian Interim Chief Legal Officer Option exercise · Restricted Share Units −3,766 7,534
2026-03-04 Savage Brian Interim Chief Legal Officer Grant or award · Restricted Share Units +11,280 11,280
2026-03-04 Weiss Amir Chief Accounting Officer Option exercise +10,679 21,508

Page 8 of 64 · 1,279 trades